Hamburg, Germany

Velocity Clinical Research, Hamburg

Founded in 2004 as Clinical Research Hamburg GmbH and acquired by Velocity Clinical Research in 2022, the experienced team at Velocity’s dedicated research site in Hamburg conducts Phase 2-4 clinical trials across a broad variety of indications. The site partners with specialists in dermatology, orthopedics, gynecology, internal medicine, and general medicine. By developing strong working relationships with local communities and having close ties with networks of cooperating practices, Velocity’s Hamburg staff provides fast, accurate patient enrollment support, even for diverse populations.

Our Hamburg team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research. With decades of research experience shared among our investigators in Hamburg, Velocity will deliver the right patients, investigators, and research staff for your next research program.

Velocity Clinical Research, Hamburg
Rahlstedter Bahnhofstraße 33, 22143, Hamburg, Germany

Phone: +49 40 6312970



Our Vision

Improve lives by making clinical research accessible to all.

Our Mission

Improve the clinical research process to accelerate the delivery of new therapies and provide exceptional care to our community.

Our experienced research team in Hamburg

The Velocity Hamburg team of physician investigators and clinical research professionals are experienced clinical researchers. All physicians are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Training records and certifications are maintained. Our clinical team is dedicated to conducting quality research in a professional and caring environment and strives on collecting quality data.

  • Dr. Christine Grigat

    Principal Investigator, Managing Director
    Christine Grigat, MD is a medical professional with a wealth of experience in the field of internal medicine and rheumatology. She obtained her medical license from the Christian-Albrecht-University in Kiel, Germany in 1992 and went on to obtain board certifications in internal medicine and rheumatology from the Aerztekammer Hamburg in 1999 and 2002 respectively. Throughout her career, Dr. Grigat has been an Assistant Physician in medical departments and practices in Germany, including the Medical Department of the Municipal Hospital in Kiel, the Department of Pathology at the University of Luebeck, the Department of Rheumatology at the General Hospital Eilbek in Hamburg. In addition to her clinical work, Dr. Grigat has also been active in scientific research, having completed her doctorate, Single electrodes-VDD-pace maker: influence of pole distance and interatrial localization on perception of auricle signal, and giving a poster presentation on the validation of CCP-Antibodies in Clinical Practice at the Congress of German Rheumatology in Leipzig. Since March 2004, Dr. Grigat has also been involved in several Phase 2 and 3 clinical studies as an principal or sub investigator, with indications including hypertension, COPD, IBS, vaccines, osteoarthritis, pain management, atopic dermatitis, depression, and others. She has been trained and certified in ICH-GCP since 2004 and regularly updates her training. Dr. Grigat is a member of the Deutsche Gesellschaft lnnere Medizin (German Association for Internal Medicine) and the DGPharMed (German Society of Pharmacological Medicine) and currently works as the Clinical Site Director at Velocity Clinical Research Hamburg GmbH, in addition to managing director and principal investigator.

  • René Martz, MD

    Principal Investigator, Managing Director
    René Martz, MD is a highly experienced medical professional with a background in human medicine and a specialization in conduction and interpretation of body plethysmography. He completed his education and training at Heinrich-Hertz Secondary School and Hamburg University in Germany, and gained valuable experience as an assistant in emergency and surgery departments at a general hospital. He holds a medical license and has been working in various positions in the medical field since 1995, including as an assistant surgeon, in an orthopedics practice, and as a Clinical Site Director for Velocity Clinical Research Hamburg GmbH. Dr. Martz has a wide range of experience in clinical studies, including several phase 2, 3, and 4 studies as an investigator or sub investigator, and receives training in ICH/GCP and IATA regularly.

Hamburg facility features

The Velocity Clinical Research, Hamburg facility is designed for the ease and comfort of study participants and to allow optimal efficiencies in performing clinical trials. Features at this site include:

  • Private examination/consultation rooms
  • Comfortable patient reception areas
  • Facilities for extended-stay pharmacokinetic studies
  • Parking
  • Nursing station
  • Secure monitoring rooms or workstations with phone & high-speed internet access
  • Multiple individual & secure workstations for research staff
  • Regulatory document processing area
  • Electronic data capture (EDC) capabilities
  • Secure record storage
  • CLIA certified research laboratory or clinical laboratory with CLIA waiver
  • Ambient and refrigerated centrifuge
  • Secured & temperature controlled investigational product storage with pharmaceutical refrigerator & freezer
  • Freezers equipped for laboratory specimens at -20 & -70 degrees Celsius
  • Backup generator/power source in the event of site power loss
  • Standard medical equipment, including ECG and Holter machines, digital and analog scales
clinical research site team
Portrait Of Smiling Female Doctor Wearing White Coat With Stethoscope Sitting Behind Desk In Office

Quality. Continuity. Velocity.